304 related articles for article (PubMed ID: 32000355)
1. New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): A Bayesian network meta-analysis.
Li H; Duan Y; Chen B; Zhao Y; Su W; Wang S; Wu J; Lu L
Medicine (Baltimore); 2020 Jan; 99(5):e18341. PubMed ID: 32000355
[TBL] [Abstract][Full Text] [Related]
2. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.
Bao J; Kan R; Chen J; Xuan H; Wang C; Li D; Xu T
Pharmacol Res; 2021 Jul; 169():105573. PubMed ID: 33766629
[TBL] [Abstract][Full Text] [Related]
3. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.
Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Pannaux M; Swedberg K
Eur J Heart Fail; 2018 Sep; 20(9):1315-1322. PubMed ID: 29806165
[TBL] [Abstract][Full Text] [Related]
4. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
Nyolczas N; Dékány M; Muk B; Szabó B
Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
[TBL] [Abstract][Full Text] [Related]
5. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
Bryan Richard S; Huang B; Liu G; Yang Y; Luo S
Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
Xie W; Zheng F; Song X; Zhong B; Yan L
Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
[TBL] [Abstract][Full Text] [Related]
7. Heart Failure With Reduced Ejection Fraction: A Review.
Murphy SP; Ibrahim NE; Januzzi JL
JAMA; 2020 Aug; 324(5):488-504. PubMed ID: 32749493
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and acceptability of Chinese herbal medicine in adult patients with heart failure and reduced ejection fraction: study protocol for a systematic review and network meta-analysis.
Liu J; Lu JJ; Zhou K; Wan J; Li Y; Cui XY; Gao Q; Huang YC; Li SN; Dong QZ; Lin Q
BMJ Open; 2018 Jun; 8(6):e015678. PubMed ID: 29921675
[TBL] [Abstract][Full Text] [Related]
9. Current drug therapy for heart failure with reduced ejection fraction.
Berliner D; Hallbaum M; Bauersachs J
Herz; 2018 Aug; 43(5):383-391. PubMed ID: 29777284
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis.
Duan Y; Lu L; Chen J; Wu C; Liang J; Zheng Y; Wu J; Rong P; Tang C
BMC Geriatr; 2018 Aug; 18(1):175. PubMed ID: 30086714
[TBL] [Abstract][Full Text] [Related]
11. Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials.
Suebsaicharoen T; Chunekamrai P; Yingchoncharoen T; Tansawet A; Issarawattana T; Numthavaj P; Thakkinstian A
Open Heart; 2023 Nov; 10(2):. PubMed ID: 37940331
[TBL] [Abstract][Full Text] [Related]
12. Non-Pharmacological Interventions in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review and Network Meta-analysis.
Li Y; He W; Jiang J; Zhang J; Ding M; Li G; Luo X; Ma Z; Li J; Ma Y; Shen Y; Han X
Arch Phys Med Rehabil; 2024 May; 105(5):963-974. PubMed ID: 37499852
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis.
Turgeon RD; Barry AR; Hawkins NM; Ellis UM
Eur J Heart Fail; 2021 Apr; 23(4):578-589. PubMed ID: 33634543
[TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
[TBL] [Abstract][Full Text] [Related]
15. Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure.
Mohiuddin S; Reeves B; Pufulete M; Maishman R; Dayer M; Macleod J; McDonagh T; Purdy S; Rogers C; Hollingworth W
BMJ Open; 2016 Dec; 6(12):e014010. PubMed ID: 28031211
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
Nochioka K; Sakata Y; Shimokawa H
Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Zheng SL; Chan FT; Nabeebaccus AA; Shah AM; McDonagh T; Okonko DO; Ayis S
Heart; 2018 Mar; 104(5):407-415. PubMed ID: 28780577
[TBL] [Abstract][Full Text] [Related]
19. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
Khazanie P; Liang L; Curtis LH; Butler J; Eapen ZJ; Heidenreich PA; Bhatt DL; Peterson ED; Yancy CW; Fonarow GC; Hernandez AF
Circ Heart Fail; 2016 Feb; 9(2):e002444. PubMed ID: 26867758
[TBL] [Abstract][Full Text] [Related]
20. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
McDonald M; Virani S; Chan M; Ducharme A; Ezekowitz JA; Giannetti N; Heckman GA; Howlett JG; Koshman SL; Lepage S; Mielniczuk L; Moe GW; O'Meara E; Swiggum E; Toma M; Zieroth S; Anderson K; Bray SA; Clarke B; Cohen-Solal A; D'Astous M; Davis M; De S; Grant ADM; Grzeslo A; Heshka J; Keen S; Kouz S; Lee D; Masoudi FA; McKelvie R; Parent MC; Poon S; Rajda M; Sharma A; Siatecki K; Storm K; Sussex B; Van Spall H; Yip AMC
Can J Cardiol; 2021 Apr; 37(4):531-546. PubMed ID: 33827756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
